133 related articles for article (PubMed ID: 2981620)
1. Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.
Smith IE; Harland SJ; Robinson BA; Evans BD; Goodhart LC; Calvert AH; Yarnold J; Glees JP; Baker J; Ford HT
Cancer Treat Rep; 1985 Jan; 69(1):43-6. PubMed ID: 2981620
[TBL] [Abstract][Full Text] [Related]
2. [A phase II study of carboplatin in small cell lung cancer].
Komatsu H; Furuse K; Nishikawa H; Minoda S; Saotome K; Nemoto E; Tani Y; Saito T; Ishiwata K; Tsutsumi M
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2313-8. PubMed ID: 2841905
[TBL] [Abstract][Full Text] [Related]
3. [A phase II study of carboplatin to bronchogenic carcinoma of the lung. Carboplatin Cooperative Study Group for Lung Carcinoma].
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2139-44. PubMed ID: 2840036
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.
Jacobs RH; Bitran JD; Deutsch M; Hoffman PC; Sinkule J; Purl S; Golomb HM
Cancer Treat Rep; 1987 Mar; 71(3):311-2. PubMed ID: 3028621
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
[TBL] [Abstract][Full Text] [Related]
10. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Furuse K; Fukuoka M; Kurita Y; Ariyoshi Y; Niitani H; Yoneda S; Fujii M; Hasegawa K; Nishiwaki Y; Tamura M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of carboplatin in head and neck cancer].
Inuyama Y; Togawa K; Morita M; Takeoda S; Kaneko T; Takemiya S; Ono I; Nomura Y; Okuda M; Kikuchi K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2131-8. PubMed ID: 3293536
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
[TBL] [Abstract][Full Text] [Related]
15. [A phase II study of carboplatin in lung cancer. The Carboplatin Cooperative Study Group].
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2781-5. PubMed ID: 2843133
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study.
Kreisman H; Ginsberg S; Propert KJ; Richards F; Graziano S; Green M
Cancer Treat Rep; 1987 Nov; 71(11):1049-52. PubMed ID: 2824045
[TBL] [Abstract][Full Text] [Related]
17. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer.
Giaccone G; Huizing M; Postmus PE; ten Bokkel Huinink WW; Koolen M; van Zandwijk N; Vermorken JB; Beijnen JH; Dalesio O; Pinedo HM
Semin Oncol; 1995 Aug; 22(4 Suppl 9):78-82. PubMed ID: 7544030
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer.
Rowinsky EK; Flood WA; Sartorius SE; Bowling MK; Wagner J; Ettinger DS
Semin Oncol; 1995 Aug; 22(4 Suppl 9):48-54. PubMed ID: 7644928
[TBL] [Abstract][Full Text] [Related]
20. Activity of JM9 in advanced ovarian cancer: a phase I-II trial.
Bramwell VH; Crowther D; O'Malley S; Swindell R; Johnson R; Cooper EH; Thatcher N; Howell A
Cancer Treat Rep; 1985 Apr; 69(4):409-16. PubMed ID: 3995511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]